300404 博濟醫藥
按盤價 
10.720 +0.080 (+0.752%)
10.720 +0.080 (+0.752%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.198 | 2.983 | 2.688 | 3.316 | 6.180 |
| 總資產報酬率 ROA (%) | 1.442 | 1.999 | 1.807 | 2.302 | 4.119 |
| 投入資產回報率 ROIC (%) | 1.724 | 2.335 | 2.072 | 2.629 | 4.822 | 邊際利潤分析 |
| 銷售毛利率 (%) | 28.832 | 30.375 | 33.336 | 37.932 | 43.220 |
| 營業利潤率 (%) | 3.185 | 2.505 | 3.173 | 4.611 | 14.508 |
| 息稅前利潤/營業總收入 (%) | 3.305 | 2.625 | 3.095 | 5.596 | 14.426 |
| 淨利潤/營業總收入 (%) | 4.085 | 4.132 | 4.892 | 6.918 | 13.418 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 161.026 | 164.956 | 97.999 | 102.612 | 81.140 |
| 價值變動淨收益/利潤總額(%) | 9.463 | 16.494 | 15.797 | 15.275 | 5.007 |
| 營業外收支淨額/利潤總額(%) | -1.519 | -0.908 | -0.052 | 20.496 | 0.110 | 償債能力分析 |
| 流動比率 (X) | 1.899 | 1.963 | 2.280 | 2.336 | 2.585 |
| 速動比率 (X) | 1.402 | 1.486 | 1.723 | 1.775 | 2.037 |
| 資產負債率 (%) | 33.617 | 30.942 | 31.410 | 29.769 | 25.640 |
| 帶息債務/全部投入資本 (%) | 22.148 | 19.069 | 22.019 | 20.436 | 16.704 |
| 股東權益/帶息債務 (%) | 347.894 | 419.210 | 348.080 | 379.442 | 486.142 |
| 股東權益/負債合計 (%) | 191.125 | 216.867 | 212.970 | 226.979 | 278.926 |
| 利息保障倍數 (X) | 19.699 | 18.448 | -40.563 | -27.485 | -146.672 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 84.395 | 68.922 | 66.687 | 69.345 | 63.470 |
| 存貨周轉天數 (天) | 140.082 | 135.379 | 178.493 | 216.752 | 236.171 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 14/11/2025 12:49 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
